Abstract

IntroductionTransgenic rats with inducible expression of the mouse Ren2 renin gene [strain name: TGR(Cyp1a1Ren2)] allow induction of various degrees of ANG II-dependent hypertension. Dietary administration of the aryl hydrocarbon indole-3-carbinol (I3C) at a dose of 0.15% induces a slowly developing form of ANG II-dependent hypertension, whereas dietary administration of a higher dose (0.3%) of I3C results in the development of ANG II-dependent malignant hypertension. Cessation of administration of 0.15% I3C results in the normalization of blood pressure, indicating the reversibility of hypertension induced by this dose of I3C. The present study was performed to determine if ANG II-dependent malignant hypertension is similarly reversible following cessation of dietary administration of 0.3% I3C. MethodsCyp1a1-Ren2 rats (n=6) were fed a normal diet containing 0.3% I3C for 11days to induce malignant hypertension. ResultsCyp1a1-Ren2 rats induced with I3C exhibited pronounced increases in systolic blood pressure (SBP) (132 ± 3–229 ± 11mm Hg, P < 0.001) and marked decreases in body weight (303 ± 4–222 ± 2 g, P < 0.001). When I3C administration was terminated, SBP decreased to 167 ± 4mm Hg (P < 0.01) and body weight increased to normal levels (309 ± 2 g, P < 0.01) within 12days. However, SBP remained significantly elevated (172 ± 1mm Hg, P < 0.01) for up to 3 weeks after termination of dietary administration of 0.3% I3C. In addition, the magnitude of the blood pressure response to intravenous bolus administration of 50 ng of ANG II (50 μL in volume) 3 weeks after cessation of dietary I3C administration was substantially higher than that observed in normotensive control rats (134 ± 1mm Hg, n=6) not previously induced with 0.3% I3C (53 ± 2 versus 38 ± 3mm Hg, P < 0.05). ConclusionsThe present findings demonstrate that transient induction of ANG II-dependent malignant hypertension results in prolonged elevations of arterial blood pressure and marked augmentation of the magnitude of the pressor response to ANG II in Cyp1a1-Ren2 transgenic rats.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call